UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 163

Sortiert nach

Robot-assisted Partial Nephrectomy for Complex (PADUA Score ≥10) Tumors: Techniques and Results from a Multicenter Experience at Four High-volume Centers

European urology, 2020-01, Vol.77 (1), p.95-100

2020

Volltextzugriff (PDF)

Role of Restaging Transurethral Resection for T1 Non–muscle invasive Bladder Cancer: A Systematic Review and Meta-analysis

European urology focus, 2018-07, Vol.4 (4), p.558-567

2018

Volltextzugriff (PDF)

Case report: Primary Ewing sarcoma of the ureter, an exceptional finding of unique manifestation of disease

Frontiers in oncology, 2023-01, Vol.12, p.1070838

2023

Volltextzugriff (PDF)

Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under "Active Surveillance" for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study

Frontiers in oncology, 2022-01, Vol.12, p.832835-832835

2022

Volltextzugriff (PDF)

The role of the general practictioner in the management of urinary calculi

Archivio italiano di urologia, andrologia, 2023-12, Vol.95 (4), p.12155

2023

Volltextzugriff (PDF)

Prospective evaluation of the role of imaging techniques and TMPRSS2:ERG mutation for the diagnosis of clinically significant prostate cancer

Frontiers in oncology, 2022-09, Vol.12, p.968384-968384

2022

Volltextzugriff (PDF)

Post-Biopsy Cell-Free DNA From Blood: An Open Window on Primary Prostate Cancer Genetics and Biology

Frontiers in oncology, 2021-05, Vol.11, p.654140-654140

2021

Volltextzugriff (PDF)

Preoperative Age and Its Impact on Long-Term Renal Functional Decline after Robotic-Assisted Partial Nephrectomy: Insights from a Tertiary Referral Center

Medicina (Kaunas, Lithuania), 2024-03, Vol.60 (3), p.463

2024

Volltextzugriff (PDF)

Could We Safely Avoid a Second Resection in Selected Patients With T1 Non-Muscle-Invasive Bladder Cancer? Preliminary Results of Cost-Effectiveness Study From HUmanitas New Indications for ReTUR (HuNIRe) Multicenter Prospective Trial

Frontiers in oncology, 2022-05, Vol.12, p.879399-879399

2022

Volltextzugriff (PDF)

Long-term Follow-up After En Bloc Transurethral Resection of Non–muscle-invasive Bladder Cancer: Results from a Single-center Experience

European urology open science (Online), 2021-04, Vol.26, p.64-71

2021

Volltextzugriff (PDF)

Male awareness of prostate cancer risk remains poor in relatives of women with germline variants in DNA‐repair genes

BJUI compass, 2023-11, Vol.4 (6), p.738-745

2023

Volltextzugriff (PDF)

External Validation and Comparison of Two Nomograms Predicting the Probability of Lymph Node Involvement in Patients subjected to Robot-Assisted Radical Prostatectomy and Concomitant Lymph Node Dissection: A Single Tertiary Center Experience in the MRI-Era

Frontiers in surgery, 2022-02, Vol.9, p.829515-829515

2022

Volltextzugriff (PDF)

Urolithiasis in Italy: an epidemiological study

Archivio italiano di urologia, andrologia, 2014-06, Vol.86 (2), p.99

2014

Volltextzugriff (PDF)

MP71-12 EVALUATING THE OUTCOMES OF BLADDER-SPARING TREATMENTS (BST) IN PATIENTS WITH BCG-UNRESPONSIVE AND BCG-EXPOSED NMIBC

The Journal of urology, 2024-05, Vol.211 (5S)

2024

Volltextzugriff (PDF)

Hydroperitoneum: A Rare Complication Performing Endoscopic Combined Intrarenal Surgery

Journal of endourology case reports, 2016-12, Vol.2 (1), p.55-58

2016

Volltextzugriff (PDF)

The Microbiome of Catheter Collected Urine in Males with Bladder Cancer According to Disease Stage

The Journal of urology, 2021-01, Vol.205 (1), p.86-93

2021

Volltextzugriff (PDF)

MP49-04 IS MULTIPARAMETRIC MRI ALWAYS NEEDED IN BIOPSY-NAÏVE PATIENTS WITH ABNORMAL DIGITAL RECTAL EXAMINATION? A SINGLE-INSTITUTIONAL EXPERIENCE COMBINING CLINICAL AND MICRO-ULTRASONOGRAPHY BASED FACTORS TO OPTIMIZE PROSTATE CANCER DETECTION

The Journal of urology, 2024-05, Vol.211 (5S)

2024

Volltextzugriff (PDF)

MP16-01 REPLACING RETUR WITH CYSTOSCOPY IN HIGH-GRADE T1 NMIBC PATIENTS: CONFIRMATORY RESULTS FROM THE HUNIRE TRIAL

The Journal of urology, 2024-05, Vol.211 (5S)

2024

Volltextzugriff (PDF)

PD30-07 HIGH-GRADE TA NON-MUSCLE INVASIVE BLADDER CANCER DEMONSTRATES HOMOGENEOUS ONCOLOGICAL OUTCOMES REGARDLESS OF EAU 2021 RISK GROUP STRATIFICATION

The Journal of urology, 2024-05, Vol.211 (5S)

2024

Volltextzugriff (PDF)

MP56-06 NOVEL RENAL CELL CARCINOMA TNM STAGING CLASSIFICATION: WHERE DOES MICROWAVE ABLATION FINDS ITS INDICATION?

The Journal of urology, 2024-05, Vol.211 (5S)

2024

Volltextzugriff (PDF)

MP35-10 LONG TERM FOLLOW UP AND RISK OF HIGH-GRADE RECURRENCE IN LOW-GRADE PTA BLADDER CANCER PATIENTS

The Journal of urology, 2024-05, Vol.211 (5S)

2024

Volltextzugriff (PDF)

Assessing long‐term upgrade risks in recurrent low‐grade non‐muscle‐invasive bladder cancer, can we deintensify the treatment?

BJU international, 2024-08, Vol.134 (2), p.195-197

2024

Volltextzugriff (PDF)

Gender-specific risk factors for renal cell carcinoma: a systematic review

Current opinion in urology, 2019-05, Vol.29 (3), p.272

2019

Volltextzugriff (PDF)

Tailored treatment including radical prostatectomy and radiation therapy + androgen deprivation therapy versus exclusive radical prostatectomy in high-risk prostate cancer patients: results from a prospective study

International Brazilian journal of urology, 2014-06, Vol.40 (3), p.322-329

2014

Volltextzugriff (PDF)

1 – 25 von 163

Suche als RSS-Feed

Aktive Filter

ThemaMedicine & Public Health

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(150)
Mit Volltextzugriff
(72)

Publikationsform

Artikel
(157)
Berichte
(6)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(18)

Menü

Weitere Dienste

Einstellungen

Robot-assisted Partial Nephrectomy for Complex (PADUA Score ≥10) Tumors: Techniques and Results from a Multicenter Experience at Four High-volume Centers

Role of Restaging Transurethral Resection for T1 Non–muscle invasive Bladder Cancer: A Systematic Review and Meta-analysis

Case report: Primary Ewing sarcoma of the ureter, an exceptional finding of unique manifestation of disease

Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under "Active Surveillance" for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study

The role of the general practictioner in the management of urinary calculi

Prospective evaluation of the role of imaging techniques and TMPRSS2:ERG mutation for the diagnosis of clinically significant prostate cancer

Post-Biopsy Cell-Free DNA From Blood: An Open Window on Primary Prostate Cancer Genetics and Biology

Evaluation of Semen Self-Sampling Yield Predictors and CTC Isolation by Multi-Color Flow Cytometry for Liquid Biopsy of Localized Prostate Cancer

Preoperative Age and Its Impact on Long-Term Renal Functional Decline after Robotic-Assisted Partial Nephrectomy: Insights from a Tertiary Referral Center

Could We Safely Avoid a Second Resection in Selected Patients With T1 Non-Muscle-Invasive Bladder Cancer? Preliminary Results of Cost-Effectiveness Study From HUmanitas New Indications for ReTUR (HuNIRe) Multicenter Prospective Trial

Long-term Follow-up After En Bloc Transurethral Resection of Non–muscle-invasive Bladder Cancer: Results from a Single-center Experience

Male awareness of prostate cancer risk remains poor in relatives of women with germline variants in DNA‐repair genes

External Validation and Comparison of Two Nomograms Predicting the Probability of Lymph Node Involvement in Patients subjected to Robot-Assisted Radical Prostatectomy and Concomitant Lymph Node Dissection: A Single Tertiary Center Experience in the MRI-Era

Urolithiasis in Italy: an epidemiological study

MP71-12 EVALUATING THE OUTCOMES OF BLADDER-SPARING TREATMENTS (BST) IN PATIENTS WITH BCG-UNRESPONSIVE AND BCG-EXPOSED NMIBC

Hydroperitoneum: A Rare Complication Performing Endoscopic Combined Intrarenal Surgery

The Microbiome of Catheter Collected Urine in Males with Bladder Cancer According to Disease Stage

MP49-04 IS MULTIPARAMETRIC MRI ALWAYS NEEDED IN BIOPSY-NAÏVE PATIENTS WITH ABNORMAL DIGITAL RECTAL EXAMINATION? A SINGLE-INSTITUTIONAL EXPERIENCE COMBINING CLINICAL AND MICRO-ULTRASONOGRAPHY BASED FACTORS TO OPTIMIZE PROSTATE CANCER DETECTION

MP16-01 REPLACING RETUR WITH CYSTOSCOPY IN HIGH-GRADE T1 NMIBC PATIENTS: CONFIRMATORY RESULTS FROM THE HUNIRE TRIAL

PD30-07 HIGH-GRADE TA NON-MUSCLE INVASIVE BLADDER CANCER DEMONSTRATES HOMOGENEOUS ONCOLOGICAL OUTCOMES REGARDLESS OF EAU 2021 RISK GROUP STRATIFICATION

MP56-06 NOVEL RENAL CELL CARCINOMA TNM STAGING CLASSIFICATION: WHERE DOES MICROWAVE ABLATION FINDS ITS INDICATION?

MP35-10 LONG TERM FOLLOW UP AND RISK OF HIGH-GRADE RECURRENCE IN LOW-GRADE PTA BLADDER CANCER PATIENTS

Assessing long‐term upgrade risks in recurrent low‐grade non‐muscle‐invasive bladder cancer, can we deintensify the treatment?

Gender-specific risk factors for renal cell carcinoma: a systematic review

Tailored treatment including radical prostatectomy and radiation therapy + androgen deprivation therapy versus exclusive radical prostatectomy in high-risk prostate cancer patients: results from a prospective study

Aktive Filter

Suchergebnisse filtern